Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

6-9 November, 2018
Postillion Convention Center,
Amsterdam, Netherlands

Increase half-life and minimise manufacturing costs through new data, case studies and technologies for peptide therapeutics

Mark your calendar for this year's meeting, held 6-9 November, 2018 in Amsterdam.

Sign up for email updates below to receive program updates and early registration offers!

Topics for this year's event:

Peptide Discovery and Drug Development Strategies
  • Peptide Discovery: Novel Selection Technologies to Identify High Affinity Ligands and Optimise Peptide Target Affinity
  • Next Generation Peptide Drug Development Strategies: Lead Optimisation, Translation to Clinic and Market
  • State of the Art Peptide Vaccine Drug Development Strategies
  • Latest Developments in Antibody or Fusion- Peptide Conjugates
  • Translating Macrocyclic and Constrained Peptides into Therapeutic Products
Preclinical & Clinical Developments, Delivery & Formulation
  • Lessons Learnt from Peptide Therapeutics in Preclinical and Clinical Development
  • Tailoring Peptides for Less Frequent Dosing and Non-Invasive Delivery
  • Industry Case Study: R&D Strategies to Advance Oral Peptide Drug Delivery Products
  • Formulation Strategies for Sustained Release of Peptide Therapeutics
Process Development, Manufacturing and CMC
  • New Technologies and Latest Developments in Solid Phase Peptide Synthesis
  • Industry Case Study on Overcoming the Challenges of Scale Up and Manufacturing of Peptide Therapeutics
  • Green Chemistry – Alternative Routes to Making Peptides
  • Innovative Purification Techniques and Downstream Processing Methodologies to Reduce Manufacturing Costs
  • Large Scale Application of Continuous Manufacturing for Peptide Therapeutics
  • Introduction of Automation and Advanced Process Monitoring Controls in Peptide Manufacturing
Analytical Strategies for Peptide Development and Manufacturing
  • Analytical Method Development, Validation and Transfer for Peptide Therapeutics
  • Characterisation Techniques, Impurity Identification and Predicting Stability in Drug Development and Manufacturing
  • Analytical Method Development and Validation for Detecting and Characterising Peptide Impurities
  • Development and Regulatory Acceptance of Quality Control Strategy for Peptide API
  • Analysis of Starting Materials in Peptide Manufacturing

PARTNERING OPPORTUNITIES AT EuroPEPTIDES 2018


Highlight your company's expertise to 300+ scientists and key decision makers working across peptide & oligonucleotide development.  For pricing and package options, please contact:

Perri Lucatello

Perri.Lucatello@knect365.com | +44 (20) 7017 7247


Linda Cole

Linda.Cole@knect365.com | +44 (20) 7017 6631